{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:53:58Z","timestamp":1790679238722,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ymthe.2018.04.025","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T17:01:39Z","timestamp":1525366899000},"page":"1783-1796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Therapeutic Benefit of Autophagy Modulation in Pompe Disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Jeong-A","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Puertollano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.04.025_bib1","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.04.025_bib2","first-page":"91","article-title":"Non-muscle involvement in late-onset glycogenosis II","volume":"32","author":"Filosto","year":"2013","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset Pompe disease: A systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2018.04.025_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/hmg\/ddu476","article-title":"Peripheral nerve and neuromuscular junction pathology in Pompe disease","volume":"24","author":"Falk","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.04.025_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymgme.2017.10.005","article-title":"Neuroimaging findings in infantile Pompe patients treated with enzyme replacement therapy","volume":"123","author":"McIntosh","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2018.04.025_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","article-title":"The genotype-phenotype correlation in Pompe disease","volume":"160C","author":"Kroos","year":"2012","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"10.1016\/j.ymthe.2018.04.025_bib7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe\u2019s disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2018.04.025_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2018.04.025_bib9","first-page":"91","article-title":"Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial","volume":"257","author":"Strothotte","year":"2010","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","article-title":"Therapeutic approaches in glycogen storage disease type II\/Pompe Disease","volume":"5","author":"Schoser","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2018.04.025_bib11","first-page":"621","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10545-010-9206-3","article-title":"Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience","volume":"33","author":"Chakrapani","year":"2010","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2018.04.025_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2018.04.025_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1750-1172-8-90","article-title":"Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy","volume":"8","author":"Prater","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2018.04.025_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.c.31321","article-title":"Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations","volume":"160C","author":"Case","year":"2012","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"10.1016\/j.ymthe.2018.04.025_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-018-0771-0","article-title":"Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy","volume":"13","author":"Parini","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2018.04.025_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","article-title":"Pompe disease: early diagnosis and early treatment make a difference","volume":"54","author":"Chien","year":"2013","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13023-016-0446-7","article-title":"Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study","volume":"11","author":"Peng","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2018.04.025_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnagi.2014.00177","article-title":"Pompe disease: from pathophysiology to therapy and back again","volume":"6","author":"Lim","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ymthe.2018.04.025_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","article-title":"Regulation mechanisms and signaling pathways of autophagy","volume":"43","author":"He","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ymthe.2018.04.025_bib22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2018.04.025_bib23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4161\/auto.19469","article-title":"Autophagy in lysosomal storage disorders","volume":"8","author":"Lieberman","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2018.04.025_bib24","doi-asserted-by":"crossref","first-page":"e1068978","DOI":"10.1080\/21675511.2015.1068978","article-title":"Pompe disease: shared and unshared features of lysosomal storage disorders","volume":"3","author":"Lim","year":"2015","journal-title":"Rare Dis."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2018.04.025_bib25","first-page":"S42","article-title":"Autophagy in skeletal muscle: implications for Pompe disease","volume":"47","author":"Shea","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2018.04.025_bib26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/cdd.2012.52","article-title":"The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)","volume":"19","author":"Nascimbeni","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2018.04.025_bib27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/nan.12214","article-title":"Impaired autophagy affects acid \u03b1-glucosidase processing and enzyme replacement therapy efficacy in late-onset glycogen storage disease type II","volume":"41","author":"Nascimbeni","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","article-title":"Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder\u2014murine Pompe disease","volume":"6","author":"Raben","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2018.04.025_bib29","doi-asserted-by":"crossref","first-page":"C1291","DOI":"10.1152\/ajpcell.00531.2009","article-title":"Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy","volume":"298","author":"Sandri","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib30","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.biocel.2013.04.023","article-title":"Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome","volume":"45","author":"Sandri","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib31","first-page":"45","article-title":"Role of autophagy in the pathogenesis of Pompe disease","volume":"26","author":"Raben","year":"2007","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4161\/auto.4591","article-title":"Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand...","volume":"3","author":"Raben","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2018.04.025_bib33","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4161\/auto.21691","article-title":"Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients","volume":"8","author":"Nascimbeni","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2018.04.025_bib34","first-page":"425","article-title":"Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy","volume":"1","author":"Wu","year":"2009","journal-title":"Aging (Albany N.Y.)"},{"key":"10.1016\/j.ymthe.2018.04.025_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cmet.2009.10.008","article-title":"Autophagy is required to maintain muscle mass","volume":"10","author":"Masiero","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2018.04.025_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4161\/auto.6.2.11137","article-title":"Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles","volume":"6","author":"Masiero","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2018.04.025_bib37","doi-asserted-by":"crossref","first-page":"R337","DOI":"10.1152\/ajpregu.00469.2004","article-title":"Mechanisms of disuse muscle atrophy: role of oxidative stress","volume":"288","author":"Powers","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib38","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.biocel.2005.04.018","article-title":"Skeletal muscle hypertrophy and atrophy signaling pathways","volume":"37","author":"Glass","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2018.04.025_bib40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","article-title":"Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease","volume":"11","author":"Lim","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.ymthe.2018.04.025_bib41","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.04.025_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2018.04.025_bib43","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1096\/fj.10-168799","article-title":"Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in\u00a0vivo technique","volume":"25","author":"Goodman","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2018.04.025_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.15252\/emmm.201606547","article-title":"Modulation of mTOR signaling as a strategy for the treatment of Pompe disease","volume":"9","author":"Lim","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2018.04.025_bib45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/japplphysiol.01253.2009","article-title":"Impaired organization and function of myofilaments in single muscle fibers from a mouse model of Pompe disease","volume":"108","author":"Xu","year":"2010","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib46","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1093\/hmg\/ddn292","article-title":"Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease","volume":"17","author":"Raben","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.04.025_bib47","doi-asserted-by":"crossref","first-page":"e15239","DOI":"10.1371\/journal.pone.0015239","article-title":"Fiber type conversion by PGC-1\u03b1 activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle","volume":"5","author":"Takikita","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.04.025_bib48","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1073\/pnas.0400541101","article-title":"Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells","volume":"101","author":"Vattem","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.04.025_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.semcdb.2004.11.009","article-title":"Role of amino acids in the translational control of protein synthesis in mammals","volume":"16","author":"Kimball","year":"2005","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tem.2009.05.008","article-title":"ATF4-dependent transcription mediates signaling of amino acid limitation","volume":"20","author":"Kilberg","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2018.04.025_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3945\/an.112.002113","article-title":"Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism","volume":"3","author":"Baird","year":"2012","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.ymthe.2018.04.025_bib52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1432-1327.1999.00780.x","article-title":"Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase","volume":"265","author":"Berlanga","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymthe.2018.04.025_bib53","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1152\/ajpendo.00457.2003","article-title":"Glucocorticoids modulate amino acid-induced translation initiation in human skeletal muscle","volume":"287","author":"Liu","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2018.04.025_bib54","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/emboj.2010.81","article-title":"The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation","volume":"29","author":"Ye","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2018.04.025_bib55","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3945\/jn.109.113621","article-title":"Stimulation of muscle protein synthesis by prolonged parenteral infusion of leucine is dependent on amino acid availability in neonatal pigs","volume":"140","author":"Wilson","year":"2010","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.ymthe.2018.04.025_bib56","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/emboj.2012.354","article-title":"Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?","volume":"32","author":"Nathan","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2018.04.025_bib57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2018.04.025_bib58","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2018.04.025_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1165\/rcmb.2014-0379RC","article-title":"Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis","volume":"53","author":"Priolo","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib60","doi-asserted-by":"crossref","first-page":"e104809","DOI":"10.1371\/journal.pone.0104809","article-title":"Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.04.025_bib61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1034\/j.1600-0854.2003.00078.x","article-title":"Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function","volume":"4","author":"Brown","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.ymthe.2018.04.025_bib62","doi-asserted-by":"crossref","first-page":"C1461","DOI":"10.1152\/ajpcell.00429.2001","article-title":"Essential role of Ca2+ -dependent phospholipase A2 in estradiol-induced lysosome activation","volume":"283","author":"Burlando","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib63","doi-asserted-by":"crossref","first-page":"ra113","DOI":"10.1126\/scisignal.aab3715","article-title":"Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21","volume":"8","author":"Guridi","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2018.04.025_bib64","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fphys.2017.00788","article-title":"mTOR as a key regulator in maintaining skeletal muscle mass","volume":"8","author":"Yoon","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib65","doi-asserted-by":"crossref","first-page":"R1251","DOI":"10.1152\/ajpregu.00212.2014","article-title":"Suppression of mTORC1 activation in acid-\u03b1-glucosidase-deficient cells and mice is ameliorated by leucine supplementation","volume":"307","author":"Shemesh","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib66","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ymgme.2012.09.011","article-title":"Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe disease","volume":"107","author":"Nishiyama","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2018.04.025_bib67","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1038\/s41598-017-14063-y","article-title":"A skeletal muscle model of infantile-onset Pompe disease with patient-specific iPS cells","volume":"7","author":"Yoshida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2018.04.025_bib68","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1073\/pnas.1716173114","article-title":"Twenty-five years of mTOR: uncovering the link from nutrients to growth","volume":"114","author":"Sabatini","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.04.025_bib69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tcb.2015.02.002","article-title":"How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy","volume":"25","author":"Feng","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib70","doi-asserted-by":"crossref","first-page":"15790","DOI":"10.1073\/pnas.1521919112","article-title":"mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2018.04.025_bib71","first-page":"183","article-title":"What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?","volume":"4","author":"Jagoe","year":"2001","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ymthe.2018.04.025_bib72","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4161\/cc.6.10.4182","article-title":"Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice","volume":"6","author":"Bonuccelli","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ymthe.2018.04.025_bib73","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2353\/ajpath.2010.090468","article-title":"Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies","volume":"176","author":"Gazzerro","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib74","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/hmg\/ddq499","article-title":"Proteasome inhibition improves the muscle of laminin \u03b12 chain-deficient mice","volume":"20","author":"Carmignac","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.04.025_bib75","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/labinvest.2016.63","article-title":"The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophy","volume":"96","author":"Assereto","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymthe.2018.04.025_bib76","doi-asserted-by":"crossref","first-page":"e2565","DOI":"10.1038\/cddis.2016.475","article-title":"Autophagy dysregulation in Danon disease","volume":"8","author":"Nascimbeni","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2018.04.025_bib77","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2018.04.025_bib78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2051-5960-2-2","article-title":"The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients","volume":"2","author":"Feeney","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2018.04.025_bib79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00424-017-2077-9","article-title":"Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia","volume":"470","author":"Sakuma","year":"2018","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ymthe.2018.04.025_bib80","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1074\/jbc.M112.399949","article-title":"Proteasome-dependent activation of mammalian target of rapamycin complex 1 (mTORC1) is essential for autophagy suppression and muscle remodeling following denervation","volume":"288","author":"Quy","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2018.04.025_bib81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5966\/sctm.2015-0409","article-title":"Metabolomic profiling of Pompe disease-induced pluripotent stem cell-derived cardiomyocytes reveals that oxidative stress is associated with cardiac and skeletal muscle pathology","volume":"6","author":"Sato","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymthe.2018.04.025_bib82","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1242\/dmm.019414","article-title":"The role of mTOR signaling in the regulation of protein synthesis and muscle mass during immobilization in mice","volume":"8","author":"You","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2018.04.025_bib83","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2018.04.025_bib84","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/WNL.33.1.34","article-title":"Improvement of muscle function in acid maltase deficiency by high-protein therapy","volume":"33","author":"Slonim","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2018.04.025_bib85","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/jnnp.50.5.587","article-title":"Protein turnover in acid maltase deficiency before and after treatment with a high protein diet","volume":"50","author":"Umpleby","year":"1987","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2018.04.025_bib86","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mus.20665","article-title":"Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy","volume":"35","author":"Slonim","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2018.04.025_bib87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BST0340007","article-title":"Coping with stress: eIF2 kinases and translational control","volume":"34","author":"Wek","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymthe.2018.04.025_bib88","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.bbamcr.2014.04.006","article-title":"Keeping the eIF2 alpha kinase Gcn2 in check","volume":"1843","author":"Castilho","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2018.04.025_bib89","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(00)00028-9","article-title":"Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-binding domain","volume":"6","author":"Dong","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2018.04.025_bib90","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/MCB.01512-07","article-title":"A novel mechanism for the control of translation initiation by amino acids, mediated by phosphorylation of eukaryotic initiation factor 2B","volume":"28","author":"Wang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib91","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1128\/MCB.25.8.3063-3075.2005","article-title":"PKR and GCN2 kinases and guanine nucleotide exchange factor eukaryotic translation initiation factor 2B (eIF2B) recognize overlapping surfaces on eIF2alpha","volume":"25","author":"Dey","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib92","doi-asserted-by":"crossref","first-page":"d8930","DOI":"10.1371\/4f84a944d8930","article-title":"A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice","volume":"4","author":"Selsby","year":"2012","journal-title":"PLoS Curr."},{"key":"10.1016\/j.ymthe.2018.04.025_bib93","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1242\/jcs.114041","article-title":"Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies","volume":"126","author":"Sandri","year":"2013","journal-title":"J.\u00a0Cell Sci."},{"issue":"R1","key":"10.1016\/j.ymthe.2018.04.025_bib94","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1093\/hmg\/ddr174","article-title":"Pompe disease gene therapy","volume":"20","author":"Byrne","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.04.025_bib95","doi-asserted-by":"crossref","first-page":"15053","DOI":"10.1038\/mtm.2015.53","article-title":"Targeted approaches to induce immune tolerance for Pompe disease therapy","volume":"3","author":"Doerfler","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2018.04.025_bib96","article-title":"Immunomodulatory, liver depot gene therapy for Pompe disease","volume":"17","author":"Bond","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib97","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.omtm.2017.08.002","article-title":"Atg5flox-derived autophagy-deficient model of Pompe disease: does it tell the whole story?","volume":"7","author":"Lim","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2018.04.025_bib98","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0925-4439(02)00229-6","article-title":"Lysosomal dysfunction in muscle with special reference to glycogen storage disease type II","volume":"1637","author":"Hesselink","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2018.04.025_bib99","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.3014","article-title":"Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine","volume":"19","author":"Kim","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.04.025_bib100","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2018.04.025_bib101","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/emmm.201202176","article-title":"Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease","volume":"5","author":"Spampanato","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2018.04.025_bib102","first-page":"1520","article-title":"DNA transfection of mammalian skeletal muscles using in\u00a0vivo electroporation","volume":"19","author":"DiFranco","year":"2009","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2018.04.025_bib103","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0076-6879(08)04021-4","article-title":"Monitoring autophagy in lysosomal storage disorders","volume":"453","author":"Raben","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib104","first-page":"R434","article-title":"Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis","volume":"277","author":"Hobler","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ymthe.2018.04.025_bib105","first-page":"416","article-title":"Novel method for detection of glycogen in cells","volume":"27","author":"Skurat","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymthe.2018.04.025_bib106","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161830203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161830203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:53:41Z","timestamp":1761501221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500161830203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":106,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S152500161830203X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.04.025","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Benefit of Autophagy Modulation in Pompe Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}